Beneficial Effects of Combination Therapy of Sitagliptin and β-carotene Drugs on Streptozotocin-induced Diabetic Rats

Authors

  • Pulye Roy Department of Pharmacy, Rajshahi University, Rajshahi-6205, Bangladesh
  • Monirul Islam Department of Pharmacy, Pabna University of Science and Technology, Pabna-6600, Bangladesh
  • Mohammad Saiful Islam Department of Pharmacy, University of Rajshahi, Rajshahi-6205, Bangladesh
  • Mamunur Rashid Department of Pharmacy, Rajshahi University, Rajshahi-6205, Bangladesh

DOI:

https://doi.org/10.3329/bpj.v23i2.48327

Keywords:

Diabetes, dyslipidemia, oxidative stress, sitagliptin and β-carotene

Abstract

Diabetes mellitus (DM), characterized by chronic hyperglycemia is one of the most common chronic diseases affecting millions of people worldwide. A significant component of the risk associated with DM is thought to be because of its abnormal lipid ‘triad’ profile. All the associated complications are mainly due to imbalance between generation of free radicals and the antioxidant systems like catalase (CAT) and super oxide dismutase (SOD) enzymes. Moreover, increased level of serum glutamate pyruvate transaminase (SGPT) and serum glutamate oxaloacetate transaminase (SGOT) are considered a consequence of hepatocyte damage. The current study was designed to investigate the antihyperglycemic and antidyslipidemic effects, oxidative stress and liver dysfunction indices of fixed dose combination therapy of sitagliptin [50 mg/70kg body weight (BW)] and β-carotene (5 mg/70kg BW) on streptozotocin (45 mg/kg BW) induced diabetic rats (SIDRs). The study showed that combination therapy induced a significant decrease in blood glucose level (BGL) from 19.09 ± 0.13 to 6.86 ± 0.11 mmol/l in comparison to the control group after daily treatment for three weeks. In case of dyslipidimic effect, combination therapy reduced total cholesterol (TC) (22.96%), triglycerides (TG) (17.54%) and low-density lipoprotein (LDL)-cholesterol (52.25%) levels significantly and increased high-density lipoprotein (HDL)-cholesterol level (55.98%) in comparison with respective diabetic control groups. We also observed that combination therapy lowered SGPT & SGOT level by 46.39% and 37.23%, respectively and increased SOD & CAT enzyme activity by 63.79% and 48.32%, respectively in comparison with diabetic control groups. These changes were significantly better than those of sitagliptin and β-carotene monotherapy. The suggestions of our findings of this research are that combination therapy is more potent than their individual monotherapy and may be beneficial for the treatment of diabetic patients with associated complications.

Bangladesh Pharmaceutical Journal 23(2): 87-95, 2020

Downloads

Download data is not yet available.
Abstract
350
PDF
363

Downloads

Published

2020-07-23

How to Cite

Roy, P., Islam, M., Islam, M. S., & Rashid, M. (2020). Beneficial Effects of Combination Therapy of Sitagliptin and β-carotene Drugs on Streptozotocin-induced Diabetic Rats. Bangladesh Pharmaceutical Journal, 23(2), 87–95. https://doi.org/10.3329/bpj.v23i2.48327

Issue

Section

Articles